Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[An update on uveitis]

E Frau1

  • 1Service d'ophtalmologie du Pr Hervé Offret, hôpital de Bicêtre, Le Kremlin-Bicêtre.

La Revue Du Praticien
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Uveitis, an inflammatory eye condition, affects 0.4% of people. While often immune-mediated, infections like toxoplasmosis can trigger uveitis, necessitating treatments like immunosuppressants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.

Carcinogenesis·2008
Same author

Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study.

Human reproduction (Oxford, England)·2007
Same author

A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.

Cancer gene therapy·2006
Same author

[Results of treating uveal melanoma with proton beam radiation: 10-year follow-up].

Journal francais d'ophtalmologie·2005
Same author

[Syphilitic chorioretinitis in the immunocompromised patient: a case report].

Journal francais d'ophtalmologie·2004
Same author

[Circumstances of choroid and ciliary body melanoma detection].

Journal francais d'ophtalmologie·2003
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Immunology

Context:

  • Uveitis affects 0.4% of the population, with anterior uveitis being the most common type (50%).
  • Human Leukocyte Antigen B27 (HLA-B27)-associated acute anterior uveitis accounts for 50% of anterior uveitis cases.
  • Sarcoidosis and Behçet disease are common systemic associations with anterior uveitis, while toxoplasmosis is a frequent cause of posterior uveitis.

Purpose:

  • To review the epidemiology, common causes, and underlying mechanisms of endogenous uveitis.
  • To discuss the role of immunological, autoimmune, and infectious factors in uveitis development.
  • To highlight the importance of CD4 T lymphocytes in uveitis perpetuation and the basis for immunosuppressive therapy.

Summary:

  • Anterior uveitis is the most prevalent form, with HLA-B27 association being significant. Systemic diseases like sarcoidosis and Behçet's disease are frequently implicated.

Related Experiment Videos

  • Infectious etiologies, particularly toxoplasmosis in posterior uveitis, remain relevant despite the shift towards immune-mediated mechanisms.
  • The pathogenesis involves initiating events determining ocular pathology, with CD4 T lymphocytes mediating perpetuation, guiding treatment with immunosuppressants like ciclosporin A.

    • Impact:

    • Provides a comprehensive overview of uveitis, aiding clinicians in diagnosis and management.
    • Emphasizes the multifactorial etiology of uveitis, integrating infectious and immune system roles.
    • Supports the use of targeted immunosuppressive therapies based on understanding uveitis pathogenesis.